Golidocitinib Plus Anthracycline-based Therapy for Untreated Nodal T-follicular Helper (TFH) Cell Lymphoma

NCT07753642 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

47

Enrollment

OTHER

Sponsor class

Conditions

Nodal T-follicular Helper Cell Lymphoma

Interventions

DRUG: Golidocitinib
DRUG: Doxorubicin
DRUG: Epirubicin

Sponsor

Sun Yat-sen University